Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan E Laulicht

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Heart Journal|September 17, 2021
Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjectsJack Ansell, Sasha Bakhru, Bryan E Laulicht, et al.
Thrombosis Research|July 30, 2016
Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparinJack E Ansell, Bryan E Laulicht, Sasha H Bakhru, et al.
Blood|November 18, 2020
Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulantsJack Ansell, Bryan E Laulicht, Sasha H Bakhru, et al.
The New England Journal of Medicine|November 6, 2014
Use of PER977 to reverse the anticoagulant effect of edoxabanJack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Thrombosis and Haemostasis|November 18, 2016
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxabanJack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Heart Journal|September 17, 2021
Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjectsJack Ansell, Sasha Bakhru, Bryan E Laulicht, et al.
Thrombosis Research|July 30, 2016
Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparinJack E Ansell, Bryan E Laulicht, Sasha H Bakhru, et al.
Blood|November 18, 2020
Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulantsJack Ansell, Bryan E Laulicht, Sasha H Bakhru, et al.
The New England Journal of Medicine|November 6, 2014
Use of PER977 to reverse the anticoagulant effect of edoxabanJack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Thrombosis and Haemostasis|November 18, 2016
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxabanJack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Pageof 1